141 related articles for article (PubMed ID: 20212343)
1. Analysis of chemokines and soluble adhesion molecules in cytomegalovirus-positive renal transplant recipients.
Obeid OE; Alzahrani AJ
J Infect Dev Ctries; 2010 Mar; 4(2):110-3. PubMed ID: 20212343
[TBL] [Abstract][Full Text] [Related]
2. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
Saghafi H; Qorashi M; Heidari A
Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
[TBL] [Abstract][Full Text] [Related]
3. Detection of cytomegalovirus-specific IGM in renal transplant recipients.
McMahon CA; Dock NL; Lentz EB; Forbes BA; Reinitz ER; Lamberson HV
J Clin Lab Anal; 1989; 3(6):350-4. PubMed ID: 2559178
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection.
Nordøy I; Müller F; Nordal KP; Rollag H; Aukrust P; Frøland SS
Clin Exp Immunol; 2000 May; 120(2):333-7. PubMed ID: 10792384
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay.
Nielsen SL; Sørensen I; Andersen HK
J Clin Microbiol; 1988 Apr; 26(4):654-61. PubMed ID: 2835388
[TBL] [Abstract][Full Text] [Related]
6. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
7. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
8. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
Chou S; Kim DY; Scott KM; Sewell DL
J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251
[TBL] [Abstract][Full Text] [Related]
10. [Detection of cytomegalovirus infection in recipients of renal transplantation].
Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients.
Toyoda M; Galfayan K; Galera OA; Petrosian A; Czer LS; Jordan SC
Transpl Immunol; 1997 Jun; 5(2):104-11. PubMed ID: 9269032
[TBL] [Abstract][Full Text] [Related]
13. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
Basson J; Tardy JC; Aymard M
Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antibody response to human cytomegalovirus in Indian renal transplant patients.
Finny GJ; Rao M; Mach M; Juneja R; Thomas PP; Jacob CK; Manayani DJ; Abraham P; Abraham M; Sridharan G
Indian J Med Res; 2001 Jun; 113():221-7. PubMed ID: 11816956
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus-specific in vitro antibody production by peripheral blood lymphocytes from renal transplant recipients with CMV infection.
Segondy M; Barat L; Mourad G; Huguet MF; Serre A; Vendrell JP
J Med Virol; 1993 Jul; 40(3):200-3. PubMed ID: 8394872
[TBL] [Abstract][Full Text] [Related]
18. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in liver transplant recipients.
Fan J; Ma WH; Qian J; Chen Z; Huang DS; Wang WL; Zheng SS
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):30-2. PubMed ID: 14607618
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus transmission in pediatric renal transplant recipients during the window period.
Gangopadhyay S; Rampersaud H; Pelletier JP; Herman L; Goldstein S; Upadhyay K
Pediatr Transplant; 2016 Feb; 20(1):172-7. PubMed ID: 26691349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
